CliniOps Application Suite now includes seamless access to trials, with advanced industry-standard security features
CliniOps, Inc., the leading provider of Hybrid and Decentralized Clinical Trials (DCT) solutions, today announced the integration of its product suite with Exostar’s Secure Access Manager (SAM). Exostar continues to gain momentum as the de-facto identity used by investigative sites to access clinical trial portals and applications to share data between sponsors and their sites.
“User experience and accessibility are the highlights of this partnership. By connecting our application to Exostar, CliniOps is now able to offer the clinical trial investigators community an industry-standard capability to quickly, easily, and painlessly switch between clinical trial platforms as they navigate the complex clinical trials process,” said Yerramalli Subramaniam, CTO of CliniOps.
“Our work with CliniOps reflects our continued commitment to bring value to our ecosystem of sponsors and sites by eliminating the burden of technology for sites charged with the research and development of tomorrow’s advanced therapies,” said Kenny Kong, Exostar’s Director of Life Sciences and Health IT. “A single, trusted identity that can be used across all sponsors and studies allows technology to be centralized, eliminating delays and ‘Login Fatigue’ that threaten timelines and performance, particularly in decentralized clinical trials.”
Although single sign-on has become more common in enabling access across multiple platforms, no such solution enables access to multiple sponsors, until now. Exostar and CliniOps together deliver frictionless access across digital data systems concurrently as part of research studies, including Electronic Data Capture (EDC), Electronic Health Records (EHR), Lab Systems, Wearables and Connected Devices.
CliniOps and Exostar empower customers to manage both internal and external user access with a single solution. “With Exostar, we gain a trusted, proven platform that helps our global customers achieve stronger security, better user experience, and further improve clinical trial efficiency,” said Avik Pal, CEO, CliniOps.
Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!